Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Impact of Pretransplant Anti-HLA Antibodies on Outcomes in Lung Transplant Candidates

Kim, Miae, Townsend, Keri R., Wood, Isabelle G., Boukedes, Steve, Guleria, Indira, Gabardi, Steven, El-Chemaly, Souheil, Camp, Phillip C., Chandraker, Anil K., Milford, Edgar L., Goldberg, Hilary J. · 2014 · American Journal of Respiratory and Critical Care Medicine

Abstract

Rationale: The prevalence of anti-HLA antibodies in lung transplant candidates and their impact on waitlist and transplant outcomes is not known. Objectives: We examined the prevalence of pretransplant anti-HLA antibodies at varying thresholds and evaluated their impact on outcomes before and after lung transplantation. Methods: We performed a single-center retrospective cohort study including all patients listed for lung transplantation between January 2008 and August 2012. Per protocol, transplant candidates were assessed by solid phase LABscreen mixed Class I and II and LABscreen Single Antigen assays. Measurements and Main Results: Among 224 patients, 34% had anti-HLA antibodies at mean fluorescent intensity (MFI) greater than or equal to 3,000 (group III), and 24% had antibodies at MFI 1,000 to 3,000 (group II). Ninety percent of the patients with pretransplant anti-HLA antibodies had class I antibodies, whereas only seven patients developed class II alone. Patients in group III were less likely to receive transplants than patients without any anti-HLA antibodies (group I) (45.5 vs. 67.7%, P = 0.005). Wait time to transplant was longer in group III than group I, although this difference did not meet statistical significance, and waitlist mortality was similar. Among transplant recipients, antibody-mediated rejection (AMR) was more frequent in group III than in group II (20% vs. 0%, P = 0.01) or group I (6.3%, P = 0.05). Conclusions: The presence of anti-HLA antibodies at the high MFI threshold (>3,000) was associated with lower transplant rate and higher rates of AMR. Screening for anti-HLA antibodies using the 3,000 MFI threshold may be important in managing transplant candidates and recipients.

Overview

Integrity signals

Registry

Crossref · 10.1164/rccm.201312-2160oc

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 22 references

Cited by

See all 72

Metadata

Authors
Kim, M., Townsend, K. R., Wood, I. G., Boukedes, S., Guleria, I., Gabardi, S., El-Chemaly, S., Camp, P. C., Chandraker, A. K., Milford, E. L., & Goldberg, H. J.
Affiliations
  • Heart Transplant Program, Center for Advanced Heart Disease, Department of Medicine
  • Department of Pharmacy Services
  • Tissue Typing Lab
  • Lung Transplant Program, Division of Pulmonary and Critical Care Medicine, Department of Medicine
  • Harvard University (US)
  • Brigham and Women's Hospital (US)
Corresponding author
Goldberg, Hilary J.
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2014-05
Volume
189
Issue
10
Pages
1234-1239
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2094516159
Cited by
72
References
22
Citations by year
2026: 1 · 2025: 1 · 2024: 3 · 2023: 7 · 2022: 5 · 2021: 8 · 2020: 4 · 2019: 6 · 2018: 12 · 2017: 7 · 2016: 7 · 2015: 10
FWCI
7.94
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Respiratory and Critical Care Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
  • Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Organ Donation and Transplantation
Keywords
HLA antibodies, lung transplantation, transplant candidates, antibody-mediated rejection, HLA class I antibodies, HLA class II antibodies, transplant waiting list, transplant rates, waitlist mortality
MeSH terms
Adult, Aged, Female, Graft Rejection, Graft Survival, Histocompatibility Testing, HLA Antigens, Humans, Immunologic Factors, Isoantibodies, Male, Middle Aged, Preoperative Care, Retrospective Studies, Tissue Donors, Cohort Studies, Biomarkers, Lung Transplantation, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of Pretransplant Anti-HLA Antibodies on Outcomes in Lung Transplant Candidates. https://app.cochat.ai/papers/10.1164/rccm.201312-2160oc
The paper
Kim, M., Townsend, K. R., Wood, I. G., Boukedes, S., Guleria, I., Gabardi, S., El-Chemaly, S., Camp, P. C., Chandraker, A. K., Milford, E. L., & Goldberg, H. J. (2014). Impact of Pretransplant Anti-HLA Antibodies on Outcomes in Lung Transplant Candidates. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201312-2160oc

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.